Bioequivalence test for non-lognormally distributed data
碩士 === 國立中央大學 === 統計研究所 === 100 === In a pharmacokinetic (PK) study, to claim a test drug under study as a generic drug, proof of the bioequivalence between the test drug and a comparative reference drug is needed. To do so, some healthy volunteers are recruited and administered with the two drugs...
Main Authors: | , |
---|---|
Other Authors: | |
Format: | Others |
Language: | zh-TW |
Published: |
2012
|
Online Access: | http://ndltd.ncl.edu.tw/handle/08410381959145479901 |
id |
ndltd-TW-100NCU05337020 |
---|---|
record_format |
oai_dc |
spelling |
ndltd-TW-100NCU053370202015-10-13T21:22:37Z http://ndltd.ncl.edu.tw/handle/08410381959145479901 Bioequivalence test for non-lognormally distributed data 針對非對數常態資料的生體相等性檢定 Kuo-sung Chan 詹國松 碩士 國立中央大學 統計研究所 100 In a pharmacokinetic (PK) study, to claim a test drug under study as a generic drug, proof of the bioequivalence between the test drug and a comparative reference drug is needed. To do so, some healthy volunteers are recruited and administered with the two drugs in a 2×2 crossover design with a reasonable wash-out time period, where the volunteers in one sequence receive the reference drug and then the test drug in two different periods, while the volunteers in the other sequence take the drugs in reverse order in the two periods. After the drug is administered to each volunteer, the drug concentrations in blood or plasma at different time points are then measured, which is referred to as the drug concentration–time curve or profile. The average bioavailability parameters such as the area under the drug concentration–time curve (AUC) is conventionally of interest for assessing the bioequivalence of the test drug to the reference drug. Conventionally, however, the distribution of the logarithm of individual AUC (denoted by logAUC) is followed the lognormal distribution. In practice, this assumption is violated and hence, in this thesis, we propose an alternative distribution, inverse gamma distribution, to satisfy the assumption of the distribution of individual logAUC. In this thesis, we consider to construct the model of individual logAUC which has subject variation and the error term are distributed by normal distribution and inverse gamma distribution, respectively, under the 2x2 crossover design. We consider using the stochastic approximation expectation- maximization algorithm to find the maximum likelihood estimates of the parameters. Then, the bioequivalence test of two drugs is inducted by estimated mean AUC. We further present some results of a simulation study investigation of the level and power performances of the purposed method and the application of the proposed test is finally illustrated by using a real data. Yuh-ing Chen 陳玉英 2012 學位論文 ; thesis 35 zh-TW |
collection |
NDLTD |
language |
zh-TW |
format |
Others
|
sources |
NDLTD |
description |
碩士 === 國立中央大學 === 統計研究所 === 100 === In a pharmacokinetic (PK) study, to claim a test drug under study as a generic drug, proof of the bioequivalence between the test drug and a comparative reference drug is needed. To do so, some healthy volunteers are recruited and administered with the two drugs in a 2×2 crossover design with a reasonable wash-out time period, where the volunteers in one sequence receive the reference drug and then the test drug in two different periods, while the volunteers in the other sequence take the drugs in reverse order in the two periods. After the drug is administered to each volunteer, the drug concentrations in blood or plasma at different time points are then measured, which is referred to as the drug concentration–time curve or profile. The average bioavailability parameters such as the area under the drug concentration–time curve (AUC) is conventionally of interest for assessing the bioequivalence of the test drug to the reference drug. Conventionally, however, the distribution of the logarithm of individual AUC (denoted by logAUC) is followed the lognormal distribution. In practice, this assumption is violated and hence, in this thesis, we propose an alternative distribution, inverse gamma distribution, to satisfy the assumption of the distribution of individual logAUC. In this thesis, we consider to construct the model of individual logAUC which has subject variation and the error term are distributed by normal distribution and inverse gamma distribution, respectively, under the 2x2 crossover design. We consider using the stochastic approximation expectation- maximization algorithm to find the maximum likelihood estimates of the parameters. Then, the bioequivalence test of two drugs is inducted by estimated mean AUC. We further present some results of a simulation study investigation of the level and power performances of the purposed method and the application of the proposed test is finally illustrated by using a real data.
|
author2 |
Yuh-ing Chen |
author_facet |
Yuh-ing Chen Kuo-sung Chan 詹國松 |
author |
Kuo-sung Chan 詹國松 |
spellingShingle |
Kuo-sung Chan 詹國松 Bioequivalence test for non-lognormally distributed data |
author_sort |
Kuo-sung Chan |
title |
Bioequivalence test for non-lognormally distributed data |
title_short |
Bioequivalence test for non-lognormally distributed data |
title_full |
Bioequivalence test for non-lognormally distributed data |
title_fullStr |
Bioequivalence test for non-lognormally distributed data |
title_full_unstemmed |
Bioequivalence test for non-lognormally distributed data |
title_sort |
bioequivalence test for non-lognormally distributed data |
publishDate |
2012 |
url |
http://ndltd.ncl.edu.tw/handle/08410381959145479901 |
work_keys_str_mv |
AT kuosungchan bioequivalencetestfornonlognormallydistributeddata AT zhānguósōng bioequivalencetestfornonlognormallydistributeddata AT kuosungchan zhēnduìfēiduìshùchángtàizīliàodeshēngtǐxiāngděngxìngjiǎndìng AT zhānguósōng zhēnduìfēiduìshùchángtàizīliàodeshēngtǐxiāngděngxìngjiǎndìng |
_version_ |
1718061140693483520 |